EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 0.215p on 10-07-2026 at 17:45:13 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.22p |
| Sell | 0.21p |
| Last Trade: | Buy 45.00 at 0.22p |
| Day's Volume: | 243,057 |
| Last Close: | 0.215p |
| Open: | 0.215p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.215p - 0.215p |
| 52wk Range: | 0.18p - 0.265p |
| Market Capitalisation: | £4.62m |
| VWAP: | 0.211173p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 45 | 0.22p | Ordinary |
15:56:19 - 10-Jul-26 |
| Buy* | 227 | 0.22p | Ordinary |
15:55:44 - 10-Jul-26 |
| Buy* | 41,513 | 0.2168p | Ordinary |
12:44:33 - 10-Jul-26 |
| Sell* | 201,272 | 0.21p | Ordinary |
08:00:26 - 10-Jul-26 |
| Buy* | 87,557 | 0.217p | Ordinary |
16:28:06 - 09-Jul-26 |
| Sell* | 4,491 | 0.21p | Ordinary |
09:08:46 - 09-Jul-26 |
| Sell* | 89,709 | 0.21p | Ordinary |
08:44:42 - 09-Jul-26 |
| Sell* | 730 | 0.21p | Ordinary |
08:38:05 - 09-Jul-26 |
| Sell* | 10,396 | 0.21p | Ordinary |
08:01:02 - 09-Jul-26 |
| Sell* | 3,185 | 0.21p | Ordinary |
15:39:01 - 07-Jul-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 26th May 2026 2:40 pm | RNS | Holding(s) in Company |
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |